Effect on Costs and Quality-adjusted Life-years of Treat-to-target Treatment Strategies Initiating Methotrexate, or Tocilizumab, or Their Combination in Early Rheumatoid Arthritis.
Maxime M A VerhoevenJanneke TekstraJacob M van LaarAttila Pethö-SchrammMichelle E A BormJohannes W J BijlsmaJohannes W G JacobsFloris P J G LafeberPaco M J WelsingPublished in: The Journal of rheumatology (2020)
Based on our analyses, early initiation of TCZ + MTX is not cost effective compared to MTX initiation in a step-up treat-to-target treatment strategy over 5 years in early RA patients.